The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours

Gastrointestinal stromal tumours (GISTs) are the most common gastrointestinal tract mesenchymal tumours. Tyrosine kinase inhibitors (TKIs) have transformed the management of advanced GIST. Imatinib was the first TKI to gain approval as management for patients with advanced GIST, establishing a new s...

Descripción completa

Detalles Bibliográficos
Autores principales: Foo, Tiffany, Goldstein, David, Segelov, Eva, Shapiro, Jeremy, Pavlakis, Nick, Desai, Jayesh, Yip, Desmond, Zalcberg, John, Price, Timothy J., Nagrial, Adnan, Chantrill, Lorraine, Burge, Matt, Karapetis, Christos S., Tebbutt, Niall, Roy, Amitesh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995292/
https://www.ncbi.nlm.nih.gov/pubmed/35290591
http://dx.doi.org/10.1007/s11523-022-00869-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995292/
https://www.ncbi.nlm.nih.gov/pubmed/35290591
http://dx.doi.org/10.1007/s11523-022-00869-y

Ejemplares similares